IDEXX Laboratories, Inc. (IDXX) Q4 2009 Earnings Results

IDEXX Laboratories Beats on EPS, Stock Down 9.45%

IDEXX Laboratories reported earnings that exceeded expectations on EPS, but the stock fell by 9.45% in reaction. This decline may reflect investor concerns or broader market trends, as there was no revenue data or guidance provided to clarify future performance.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.51	N/A	+13.84%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Unknown

No transcript is on record for this earnings call, and the analysis is based solely on the numerical results.

IDEXX Laboratories Beats on EPS, Stock Down 9.45%

Key numbers

Management commentary

IDEXX Laboratories, Inc.

More earnings this week

IDEXX Laboratories Beats on EPS, Stock Down 9.45%

Key numbers

Management commentary